Fougera and Protherics announce increased DigiFab production to counteract shortage.
Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (
Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.